Activating dormant strongyloidiasis secondary to COVID-19 treatment
- 1 February 2022
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Medical and Clinical Case Reports
- Vol. 9 (1), 015-017
- https://doi.org/10.17352/2455-5282.000148
Abstract
The SARS-CoV-2 pandemic has grown into a major global concern with huge efforts to combat the spread. Exaggerated inflammatory response plays a major role in which was the rationale to use corticosteroids to treat patients. However, multiple studies showed an association between opportunistic and bacterial infections with corticosteroid therapy. We report a case of a 76 year old patient diagnosed with COVID-19 treated with 10 days Dexamethasone and Remdesivir who presented with abdominal symptoms with eosinophilia. Biopsy and stool studies revealed Strongyloides stercoralis larvae. The patient was treated with 2 doses of Ivermectin with significant clinical resolution. Clinician should have high clinical suspicion for Strongloydiasis in patients who have lived or visited endemic areas and for patients with unexplained eosinophilia. Prompt treatment with Ivermectin is crucial for confirmed cases and high risk cases where obtaining a diagnosis is unfeasible.Keywords
This publication has 16 references indexed in Scilit:
- Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the LiteratureFrontiers in Medicine, 2020
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortalityInternational Journal of Antimicrobial Agents, 2020
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreakJournal of Autoimmunity, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trialThe Lancet Infectious Diseases, 2019
- Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic CountriesThe American Journal of Tropical Medicine and Hygiene, 2017
- Strongyloides stercoralis infectionBMJ, 2013
- Severe strongyloidiasis: a systematic review of case reportsBMC Infectious Diseases, 2013
- Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralisCurrent Opinion in Infectious Diseases, 2012
- INFECTIONS ASSOCIATED WITH STEROID USEInfectious Disease Clinics of North America, 2001